🔎 Trials Near Me

Hjem › Lungekreft › Ohio › Cleveland

Kliniske studier for Lungekreft i Cleveland, OH

26 studier for Lungekreft søker deltakere på steder i og rundt Cleveland (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

The Vanguard Study: Testing a New Way to Screen for Cancer

RekruttererFrivillige helsepersonell ønskes velkommen
  • Louis Stokes Cleveland VA Medical Center, Cleveland
Alder 45 til 75 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06995898

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

RekruttererFase 3
  • Case Western Reserve University, Cleveland
  • MetroHealth Medical Center, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi unna
  • og 1 flere
Alder 70 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06096844

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

RekruttererFase 3
  • MetroHealth Medical Center, Cleveland
  • Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • og 2 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT04267848

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

RekruttererFase 3
  • Case Western Reserve University, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi unna
  • og 2 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT04181060

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

RekruttererFase 1/2
  • The Cleveland Clinic Taussig Cancer Center, Cleveland
Alder 12 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04585750

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

RekruttererFase 3
  • University Hospitals Cleveland Medical Center, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07222566

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

RekruttererFase 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • UH Minoff Health Center at Chagrin Highlands, Orange · 12 mi unna
  • University Hospitals Seidman Cancer Center at UH Mentor Health Center, Mentor · 22 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06758401

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

RekruttererFase 1/2
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06618287

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

RekruttererFase 2
  • Research Site, Cleveland
Alder 18 til 95 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT05061550

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors

RekruttererFase 2
  • University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07104630

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

RekruttererFase 2/3
  • The Cleveland Clinic Cancer Center At Fairview Hospital, Moll Pavilion, Cleveland
  • Cleveland Clinic, Cleveland
  • Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06712316

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

RekruttererFase 2/3
  • University Hospitals Cleveland Medical Center, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07100080

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

RekruttererFase 1/2
  • Case Western Reserve University, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06287775

A Study Evaluating a New Radiation Treatment Workflow (NGDS)

Rekrutterer
  • University Hospital Cleveland Medical Center, Cleveland
Alder 21 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07824583

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

RekruttererFase 1/2
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT05786924

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

RekruttererFase 1/2
  • Case Western Reserve University, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07012031

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

RekruttererFase 1
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06343402

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

RekruttererFase 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • The Cleveland Clinic Cancer Center at Fairview Hospital, Moll Pavilion, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • og 1 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 1. sep. 2026 · NCT06712355

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

RekruttererFase 3
  • Case Western Reserve University, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi unna
  • UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT05624996

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

RekruttererFase 1
  • University Hospital - Cleveland Medical Center, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 5. aug. 2026 · NCT07444814

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

RekruttererFase 1/2
  • University Hospitals Cleveland Medical Center, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 30. jun. 2026 · NCT06162221

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

RekruttererObservasjonsstudie
  • University Hospitals Seidman Cancer Center, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 23. feb. 2026 · NCT05974150

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Rekrutterer
  • Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 19. feb. 2026 · NCT02984761

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Cleveland Clinic, Cleveland
Alder 40 og eldre · Alle kjønn · Oppdatert 20. jan. 2026 · NCT05366881

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RekruttererObservasjonsstudie
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi unna
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

RekruttererFase 1/2
  • Cleveland Clinic, Cleveland
Alder 18 og eldre · Alle kjønn · Oppdatert 24. okt. 2025 · NCT06228326

Lungekreft-studier i andre byer

Andre studier i Cleveland

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.